Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ARFGEF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNTNAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100505555 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTP4A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAX6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCSK7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIAPH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGFG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC25-GNG10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IREB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTSS1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on